Epicutaneous application of house dust mite induces allergic skin inflammation and atopic march to the lung upon airway allergen challenge
Clinical Immunology · 2026-02 · 283 · 110653
DOI: 10.1016/j.clim.2025.110653 ↗At a glance
Journal article in Clinical Immunology, 2026-02. Written by Fatima Hubaishi and 7 co-authors. Institution: Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada. Major MEDLINE topics: Dermatitis, Atopic, Lung, Pyroglyphidae, Antigens, Dermatophagoides. Cited 2 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: Santé, Canadian Institutes of Health Research.
Abstract (original language)
Atopic dermatitis (AD) in infants is associated with increased risk of developing other allergic diseases, including asthma. This progression is known as atopic march (AM). We established a murine AM model by first inducing AD-like skin inflammation to house dust mite (HDM) allergen. Mice were subsequently challenged with HDM delivered to the lung. Our data show that epicutaneous sensitization with HDM increased serum IgE, ear thickness, and immune cell infiltration into the skin, accompanied by an increase in CD4+ tissue-resident memory T cells (Trm) in the lung. Following pulmonary HDM challenge, eosinophil influx and T2 inflammation were increased in the lung. Together, our data suggest communication between the skin and lung, where allergen sensitization on the skin increases lung Trm and amplifies the T2 allergic response to lung allergen challenge. This clinically relevant model could help identify novel targets for local interventions to reduce the progression of AD to asthma.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
- Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
- Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada. Electronic address: elizabeth.fixman@mcgill.ca.
Funding
- Santé
- Canadian Institutes of Health Research
Cite
APA
Hubaishi, F., Karkout, R., Labrie, L., Alyazidi, R. M., Solomon, M., Aldossary, H., Ward, B. J., & Fixman, E. D. (2026). Epicutaneous application of house dust mite induces allergic skin inflammation and atopic march to the lung upon airway allergen challenge. Clinical Immunology, 283, 110653. https://doi.org/10.1016/j.clim.2025.110653
Vancouver
Hubaishi F, Karkout R, Labrie L, Alyazidi RM, Solomon M, Aldossary H, et al. Epicutaneous application of house dust mite induces allergic skin inflammation and atopic march to the lung upon airway allergen challenge. Clinical Immunology. 2026;283:110653. doi:10.1016/j.clim.2025.110653
BibTeX
@article{Hubaishi2026,
author = {Hubaishi, Fatima and Karkout, Rami and Labrie, Lydia and Alyazidi, Raidan Mohammed and Solomon, Magan and Aldossary, Haya and Ward, Brian J and Fixman, Elizabeth D},
title = {Epicutaneous application of house dust mite induces allergic skin inflammation and atopic march to the lung upon airway allergen challenge},
journal = {Clinical Immunology},
year = {2026},
volume = {283},
pages = {110653},
doi = {10.1016/j.clim.2025.110653}
}
EUVIMED